Skip Navigation


Human Molecular Genetics Advance Access originally published online on March 16, 2005
Human Molecular Genetics 2005 14(9):1161-1169; doi:10.1093/hmg/ddi128
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
14/9/1161    most recent
ddi128v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sun, X.-M.
Right arrow Articles by Soutar, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, X.-M.
Right arrow Articles by Soutar, A. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia

Xi-Ming Sun1,{dagger}, Emily R. Eden1,{dagger}, Isabella Tosi1, Clare K. Neuwirth1, David Wile2, Rossi P. Naoumova1 and Anne K. Soutar1,*

1MRC Clinical Sciences Centre, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK and 2Department of Clinical Biochemistry, University Hospital, Aintree, Liverpool L9 7AL, UK

* To whom correspondence should be addressed. Tel: +44 2083832324; Fax: +44 2083832077; Email: anne.soutar{at}csc.mrc.ac.uk

Received January 11, 2005; Revised February 7, 2005; Accepted March 10, 2005

Typically, autosomal dominant familial hypercholesterolaemia (FH) is caused by mutations in the low density lipoprotein (LDL) receptor or apolipoprotein B genes that result in defective clearance of plasma LDL by the liver, but a third gene (PCSK9), encoding a putative proprotein convertase, has recently been implicated. Two independent microarray studies support a role for PCSK9 in sterol metabolism and adenoviral-mediated over-expression of PCSK9 in mouse liver depletes hepatic LDL-receptor protein, but the mechanism by which dominant mutations cause human FH is unclear. We have identified the D374Y mutant of PCSK9 in three FH families of English origin; all 12 affected individuals have unusually severe hypercholesterolaemia and require more stringent treatment than typical FH patients, who are heterozygous for defects in the LDL receptor. We have stably expressed wild-type (WT) and variant PCSK9 in McArdle-7777 rat hepatoma cells and shown by confocal microscopy that all forms of PCSK9 co-localize with protein disulphide isomerase in the ER whether or not they can be autocleaved. Expression of the proposed pathogenic variants, but not of WT, S386A or F216L PCSK9, increases secretion of apolipoprotein B100-containing lipoproteins from the cells by 2–4-fold probably by reducing the degradation of nascent protein; no differences in LDL-receptor content were observed in cells expressing WT, S386A or F216L PCSK9 and only a small reduction in cells expressing the D374Y or S127R mutants. This suggests that the variants of PCSK9 found in FH influence the secretion of apoB-containing lipoproteins, providing an explanation for the marked increase in circulating LDL in heterozygous carriers.

{dagger} The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
Y. Luo, L. Warren, D. Xia, H. Jensen, T. Sand, S. Petras, W. Qin, K. S. Miller, and J. Hawkins
Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice
J. Lipid Res., August 1, 2009; 50(8): 1581 - 1588.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc GenetHome page
C.-C. Huang, M. Fornage, D. M. Lloyd-Jones, G. S. Wei, E. Boerwinkle, and K. Liu
Longitudinal Association of PCSK9 Sequence Variations With Low-Density Lipoprotein Cholesterol Levels: The Coronary Artery Risk Development in Young Adults Study
Circ Cardiovasc Genet, August 1, 2009; 2(4): 354 - 361.
[Abstract] [Full Text] [PDF]

Home page
 ESC Textbook of Cardiovascular MedicineHome page
S. G. Priori, C. Napolitano, S. E. Humphries, and J. Skipworth
CHAPTER 9 Genetics of Cardiovascular Diseases
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M Abifadel, L Bernier, G Dubuc, G Nuel, J-P Rabes, J Bonneau, A Marques, M Marduel, M Devillers, A Munnich, et al.
A PCSK9 variant and familial combined hyperlipidaemia
J. Med. Genet., December 1, 2008; 45(12): 780 - 786.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Blesa, S. Vernia, A.-B. Garcia-Garcia, S. Martinez-Hervas, C. Ivorra, V. Gonzalez-Albert, J. F. Ascaso, J. C. Martin-Escudero, J. T. Real, R. Carmena, et al.
A New PCSK9 Gene Promoter Variant Affects Gene Expression and Causes Autosomal Dominant Hypercholesterolemia
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3577 - 3583.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. S. Fisher, P. L. Surdo, S. Pandit, M. Mattu, J. C. Santoro, D. Wisniewski, R. T. Cummings, A. Calzetta, R. M. Cubbon, P. A. Fischer, et al.
Effects of pH and Low Density Lipoprotein (LDL) on PCSK9-dependent LDL Receptor Regulation
J. Biol. Chem., July 13, 2007; 282(28): 20502 - 20512.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
S E Humphries, R A Whittall, C S Hubbart, S Maplebeck, J A Cooper, A K Soutar, R Naoumova, G R Thompson, M Seed, P N Durrington, et al.
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk
J. Med. Genet., December 1, 2006; 43(12): 943 - 949.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Lambert, A.-L. Jarnoux, T. Pineau, O. Pape, M. Chetiveaux, C. Laboisse, M. Krempf, and P. Costet
Fasting Induces Hyperlipidemia in Mice Overexpressing Proprotein Convertase Subtilisin Kexin Type 9: Lack of Modulation of Very-Low-Density Lipoprotein Hepatic Output by the Low-Density Lipoprotein Receptor
Endocrinology, October 1, 2006; 147(10): 4985 - 4995.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Cameron, O. L. Holla, T. Ranheim, M. A. Kulseth, K. E. Berge, and T. P. Leren
Effect of mutations in the PCSK9 gene on the cell surface LDL receptors
Hum. Mol. Genet., May 1, 2006; 15(9): 1551 - 1558.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. E. Berge, L. Ose, and T. P. Leren
Missense Mutations in the PCSK9 Gene Are Associated With Hypocholesterolemia and Possibly Increased Response to Statin Therapy
Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1094 - 1100.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Costet, B. Cariou, G. Lambert, F. Lalanne, B. Lardeux, A.-L. Jarnoux, A. Grefhorst, B. Staels, and M. Krempf
Hepatic PCSK9 Expression Is Regulated by Nutritional Status via Insulin and Sterol Regulatory Element-binding Protein 1c
J. Biol. Chem., March 10, 2006; 281(10): 6211 - 6218.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. P. Naoumova, I. Tosi, D. Patel, C. Neuwirth, S. D. Horswell, A. D. Marais, C. van Heyningen, and A. K. Soutar
Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene: Long-Term Follow-Up and Treatment Response
Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2654 - 2660.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.